Oxadiazole-isopropylamides as potent and noncovalent proteasome inhibitors.

Oxadiazole-isopropylamides as potent and noncovalent proteasome inhibitors.
复制标题

DOI:
10.1021/jm400221d
复制
发表时间:
2013-05-23
影响因子:
7.3
通讯作者:
Sebti, Said M.
Sebti, Said M.
中科院分区:
医学1区
文献类型:
--
作者:
Ozcan, Sevil;Kazi, Aslamuzzaman;Marsilio, Frank;Fang, Bin;Guida, Wayne C.;Koomen, John;Lawrence, Harshani R.;Sebti, Said M.

文献摘要

参考文献

被引文献

相似文献

Screening of the 50,000 ChemBridge compound library led to the identification of the oxadiazole-isopropylamide 1 (PI-1833) which inhibited CT-L activity (IC50 0.60 μM) with little effects on the other 2 major proteasome proteolytic activities, T-L and PGPH-L. LC/MS-MS and dialysis show that 1 is a non-covalent and rapidly reversible CT-L inhibitor. Focused library synthesis provided 11ad (PI-1840) with CT-L activity (IC50 27 nM). Detailed SAR studies indicate that the amide moiety and the 2 phenyl rings are sensitive toward modifications. Hydrophobic residues, such as propyl or butyl, in the para-position (not ortho or meta) of the A-ring and a meta-pyridyl group as B-ring significantly improve activity. Compound 11ad (IC50 0.37 μM) is more potent than 1 (IC50 3.5 μM) at inhibiting CT-L activity in intact MDA-MB-468 human breast cancer cells and inhibiting their survival. The activity of 11ad warrants further pre-clinical investigation of this class as non-covalent proteasome inhibitors.
DOI: 10.1038/386463a0
发表时间: 1997-04-03
期刊: NATURE
影响因子: 64.8
作者:
Groll, M;Ditzel, L;Huber, R
通讯作者: Huber, R
DOI: 10.1021/jm049660v
发表时间: 2004-09-23
影响因子: 7.3
作者:
Furet, P;Imbach, P;García- Echeverría, C
通讯作者: García- Echeverría, C
DOI: 10.1021/jm000350w
发表时间: 2001-05-10
影响因子: 7.3
作者:
Gezginci, MH;Martin, AR;Franzblau, SG
通讯作者: Franzblau, SG
DOI: 10.1006/jmbi.2001.4869
发表时间: 2001-08-17
影响因子: 5.6
作者:
Groll, M;Koguchi, Y;Kohno, J
通讯作者: Kohno, J
DOI: 10.1016/j.bmcl.2006.03.033
发表时间: 2006-06-15
影响因子: 2.7
作者:
Basse, Nicolas;David, Papapostolou;Vanderesse, Rgis
通讯作者: Vanderesse, Rgis